A case of asymmetric insulin-derived localised amyloid deposition associated with long-acting insulin analog administration
Amyloid
.
2022 Sep;29(3):205-207.
doi: 10.1080/13506129.2022.2047019.
Epub 2022 Mar 7.
Authors
Keiji Hirai
1
,
Shigeki Imamura
2
,
Aizan Hirai
2
,
Naoka Umemoto
3
,
Hisashi Oshiro
4
,
Fuyuki Kametani
5
,
Nagaaki Katoh
6
,
Masahide Yazaki
7
,
Susumu Ookawara
1
,
Yoshiyuki Morishita
1
Affiliations
1
Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
2
Department of Internal Medicine, Chiba Cerebral and Cardiovascular Center, Chiba, Japan.
3
Department of Dermatology, Jichi Medical University, Saitama Medical Center, Saitama, Japan.
4
Department of Diagnostic Pathology, Jichi Medical University, Saitama Medical Center, Saitama, Japan.
5
Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
6
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
7
Department of Biomedical Laboratory Sciences, Shinshu University School of Health Sciences, Matsumoto, Japan.
PMID:
35254180
DOI:
10.1080/13506129.2022.2047019
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Amyloid
Diabetes Mellitus, Type 1*
Humans
Insulin*
Insulin, Long-Acting
Substances
Amyloid
Insulin
Insulin, Long-Acting